Skip to content
BY-NC-ND 3.0 license Open Access Published by De Gruyter June 22, 2014

CA-125 of fetal origin can act as a ligand for dendritic cell-specific ICAM-3-grabbing non-integrin

  • Ninoslav Mitić EMAIL logo , Bojana Milutinović and Miroslava Janković

Abstract

CA-125 (coelomic epithelium-related antigen) forms the extracellular portion of transmembrane mucin 16 (MUC16). It is shed after proteolytic degradation. Due to structural heterogeneity, CA-125 ligand capacity and biological roles are not yet understood. In this study, we assessed CA-125 as a ligand for dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN), which is a C-type lectin showing specificity for mannosylated and fucosylated structures. It plays a role as a pattern recognition molecule for viral and bacterial glycans or as an adhesion receptor. We probed a human DC-SIGN-Fc chimera with CA-125 of fetal or cancer origin using solid- or fluid-phase binding and inhibition assays. The results showed that DC-SIGN binds to CA-125 of fetal origin and that this interaction is carbohydrate-dependent. By contrast, cancerderived CA-125 displayed negligible binding. Inhibition assays indicated differences in the potency of CA-125 to interfere with DC-SIGN binding to pathogen-related glycoconjugates, such as mannan and Helicobacter pylori antigens. The differences in ligand properties between CA-125 of fetal and cancer origin may be due to specificities of glycosylation. This might influence various functions of dendritic cells based on their subset diversity and maturation-related functional capacity.

[1] Montz, F.J. CA125 in: Serological Cancer Markers (Sell, S. Ed.), The Humana Press Totowa, NJ, 1992, 417–425. http://dx.doi.org/10.1007/978-1-4612-0401-5_1910.1007/978-1-4612-0401-5_19Search in Google Scholar

[2] Scholler, N. and Urban, N. CA125 in ovarian cancer. Biomark. Med. 1 (2007) 513–523. DOI: 10.2217/17520363.1.4.513. http://dx.doi.org/10.2217/17520363.1.4.51310.2217/17520363.1.4.513Search in Google Scholar PubMed PubMed Central

[3] Seki, K., Kikuchi, Y., Uesato, T. and Kato, K. Increased serum CA 125 levels during the first trimester of pregnancy. Acta Obstet. Gynecol. Scand. 65 (1986) 583–585. http://dx.doi.org/10.3109/0001634860915839210.3109/00016348609158392Search in Google Scholar PubMed

[4] Carson, D.D., DeSouza, M.M., Kardon, R., Zhou, X., Lagow, E. and Julian, J. Mucin expression and function in the female reproductive tract. Hum. Reprod. Update 4 (1998) 459–464. http://dx.doi.org/10.1093/humupd/4.5.45910.1093/humupd/4.5.459Search in Google Scholar PubMed

[5] Redžović, A., Laškarin, G., Dominović, M., Haller, H. and Rukavina, D. Mucins help to avoid alloreactivity at the maternal fetal interface. Clin. Dev. Immunol. (2013) 542152. DOI: 10.1155/2013/542152. 10.1155/2013/542152Search in Google Scholar PubMed PubMed Central

[6] Gipson, I.K., Blalock, T., Tisdale, A., Spurr-Michaud, S., Allcorn, S., Stavreus-Evers, A. and Gemzell, K. MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence. Biol. Reprod. 78 (2008) 134–142. http://dx.doi.org/10.1095/biolreprod.106.05834710.1095/biolreprod.106.058347Search in Google Scholar PubMed

[7] Clark, G.F., Dell, A., Morris, H.R., Patankar, M.S. and Easton, R.L. The species recognition system: a new corollary for the human fetoembryonic defense system hypothesis. Cells Tissues Organs 168 (2001) 113–121. http://dx.doi.org/10.1159/00001681210.1159/000016812Search in Google Scholar PubMed

[8] Clark, G.F. and Patankar, M.S. Opinion: Hu-FEDS: in search of ‘universal self’. Mol. Hum. Reprod. 3 (1997) 985–987. http://dx.doi.org/10.1093/molehr/3.11.98510.1093/molehr/3.11.985Search in Google Scholar PubMed

[9] Seelenmeyer, C., Wegehingel, S., Lechner, J. and Nickel, W. The cancer antigen CA125 represents a novel counter receptor for galectin-1. J. Cell. Sci. 116 (2003) 1305–1318. http://dx.doi.org/10.1242/jcs.0031210.1242/jcs.00312Search in Google Scholar PubMed

[10] Argüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J. and Panjwani, N. Association of cell surface mucins with galectin-3 contributes to the ocular surface epithelial barrier. J. Biol. Chem. 284 (2009) 23037–23045. DOI: 10.1074/jbc.M109.033332. http://dx.doi.org/10.1074/jbc.M109.03333210.1074/jbc.M109.033332Search in Google Scholar PubMed PubMed Central

[11] Belisle, J.A., Horibata, S., Jennifer, G.A., Petrie, S., Kapur, A., André, S., Gabius, H.J., Rancourt, C., Connor, J., Paulson, J. C. and Patankar, M.S. Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol. Cancer 9 (2010) 118. DOI: 10.1186/14764598-9-118. http://dx.doi.org/10.1186/1476-4598-9-118Search in Google Scholar

[12] Mitić N.M., Milutinović B.S. and Janković M.M. Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acidbinding Ig-like lectins (Siglecs). Dis. Markers 32 (2012) 187–194. DOI: 10.3233/DMA-2011-0872. http://dx.doi.org/10.1155/2012/309203Search in Google Scholar

[13] Chen, S.H., Dallas, M.R., Balzer, E.M. and Konstantopoulos, K. Mucin 16 is a functional selectin ligand on pancreatic cancer cells. FASEB J. 26 (2012) 1349–1359. DOI: 10.1096/fj.11-195669. http://dx.doi.org/10.1096/fj.11-19566910.1096/fj.11-195669Search in Google Scholar

[14] Rump, A., Morikawa, Y., Tanaka, M., Minami, S., Umesaki, N., Takeuchi, M. and Miyajima, A. Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion. J. Biol. Chem. 279 (2004) 9190–9198. http://dx.doi.org/10.1074/jbc.M31237220010.1074/jbc.M312372200Search in Google Scholar

[15] Patankar, M.S., Jing, Y., Morrison, J.C., Belisle, J.A., Lattanzio, F.A., Deng, Y., Wong, N.K., Morris, H.R., Dell, A. and Clark, G.F. Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125. Gynecol. Oncol. 99 (2005) 704–713. http://dx.doi.org/10.1016/j.ygyno.2005.07.03010.1016/j.ygyno.2005.07.030Search in Google Scholar

[16] Kui Wong, N., Easton, R.L., Panico, M., Sutton-Smith, M., Morrison, J.C., Lattanzio, F.A., Morris, H.R., Clark, G.F., Dell, A. and Patankar, M.S. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125. J. Biol. Chem. 278 (2003) 28619–28634. http://dx.doi.org/10.1074/jbc.M30274120010.1074/jbc.M302741200Search in Google Scholar

[17] Geijtenbeek, T.B., Torensma, R., van Vliet, S.J., van Duijnhoven, G.C., Adema, G.J., van Kooyk, Y. and Figdor, C.G. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575–585. http://dx.doi.org/10.1016/S0092-8674(00)80693-510.1016/S0092-8674(00)80693-5Search in Google Scholar

[18] Engering, A., Geijtenbeek, T.B., van Vliet, S.J., Wijers, M., van Liempt, E., Demaurex, N., Lanzavecchia, A., Fransen, J., Figdor, C.G., Piguet, V. and van Kooyk, Y. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol. 168 (2002) 2118–2126. http://dx.doi.org/10.4049/jimmunol.168.5.211810.4049/jimmunol.168.5.2118Search in Google Scholar PubMed

[19] Figdor, C.G., van Kooyk, Y. and Adema, G.J. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2 (2002) 77–84. http://dx.doi.org/10.1038/nri72310.1038/nri723Search in Google Scholar PubMed

[20] Cambi, A. and Figdor, C.G Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell. Biol. 15 (2003) 539–546. http://dx.doi.org/10.1016/j.ceb.2003.08.00410.1016/j.ceb.2003.08.004Search in Google Scholar PubMed

[21] Saeland, E., de Jong, M.A., Nabatov, A.A., Kalay, H., Geijtenbeek, T.B. and van Kooyk, Y. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol. Immunol. 46 (2009) 2309–2316. DOI: 10.1016/j.molimm.2009.03.025. http://dx.doi.org/10.1016/j.molimm.2009.03.02510.1016/j.molimm.2009.03.025Search in Google Scholar PubMed

[22] Stax, M.J., van Montfort, T., Sprenger, R.R., Melchers, M., Sanders, R.W., van Leeuwen, E., Repping, S., Pollakis, G., Speijer, D. and Paxton, W.A. Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes. Virology 391 (2009) 203–211. DOI: 10.1016/j.virol.2009.06.011. http://dx.doi.org/10.1016/j.virol.2009.06.01110.1016/j.virol.2009.06.011Search in Google Scholar PubMed

[23] Laškarin, G., Medančić, S.S., Redžović, A., Durić, D. and Rukavina, D. Specific decidual CD14(+) cells hamper cognate NK cell proliferation and cytolytic mediator expression after mucin 1 treatment in vitro. J. Reprod. Immunol. 95 (2012) 36–45. DOI: 10.1016/j.jri.2012.06.002. http://dx.doi.org/10.1016/j.jri.2012.06.00210.1016/j.jri.2012.06.002Search in Google Scholar PubMed

[24] Janković, M.M. and Tapušković, B.S. Molecular forms and microheterogeneity of oligosaccharide chains of pregnancy-associated CA125. Hum. Reprod. 20 (2005) 2632–2638. http://dx.doi.org/10.1093/humrep/dei09510.1093/humrep/dei095Search in Google Scholar PubMed

[25] Milutinović, B.S. and Janković, M.M. Analysis of the protein and glycan parts of CA125 antigen from human amniotic fluid. Arch. Biol. Sci. 59 (2007) 97–103. http://dx.doi.org/10.2298/ABS0702097M10.2298/ABS0702097MSearch in Google Scholar

[26] García-Vallejo, J.J. and van Kooyk, Y. Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis. Immunol. Rev. 230 (2009) 22–37. DOI: 10.1111/j.1600-065X.2009.00786.x. http://dx.doi.org/10.1111/j.1600-065X.2009.00786.x10.1111/j.1600-065X.2009.00786.xSearch in Google Scholar PubMed

[27] Mitchell, D.A., Fadden, A.J. and Drickamer, K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J. Biol. Chem. 276 (2001) 28939–28945. http://dx.doi.org/10.1074/jbc.M10456520010.1074/jbc.M104565200Search in Google Scholar PubMed

[28] Appelmelk, B.J., van Die, I., van Vliet, S.J., Vandenbroucke-Grauls, C.M., Geijtenbeek, T.B. and van Kooyk, Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 170 (2003) 1635–1639. http://dx.doi.org/10.4049/jimmunol.170.4.163510.4049/jimmunol.170.4.1635Search in Google Scholar PubMed

[29] Janković, M.M. and Milutinović, B.S. Glycoforms of CA125 antigen as a possible cancer marker. Cancer Biomark. 4 (2008) 35–42. Search in Google Scholar

[30] Chen, K., Gentry-Maharaj, A., Burnell, M., Steentoft, C., Marcos-Silva, L., Mandel, U., Jacobs, I., Dawnay, A., Menon, U. and Blixt, O. Microarray glycoprofiling of CA125 improves differential diagnosis of ovarian cancer. J. Proteome Res. 12 (2013) 1408–1418. DOI: 10.1021/pr3010474. http://dx.doi.org/10.1021/pr301047410.1021/pr3010474Search in Google Scholar PubMed

[31] Saldova, R., Struwe, W.B., Wynne, K., Elia, G., Duffy, M.J. and Rudd, P.M. Exploring the glycosylation of serum CA125. Int. J. Mol. Sci. 14 (2013) 15636–15654. DOI: 10.3390/ijms140815636. http://dx.doi.org/10.3390/ijms14081563610.3390/ijms140815636Search in Google Scholar PubMed PubMed Central

[32] Feinberg, H., Mitchell, D.A., Drickamer, K. and Weis, W.I. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294 (2001) 2163–2166. http://dx.doi.org/10.1126/science.106637110.1126/science.1066371Search in Google Scholar PubMed

[33] Geijtenbeek, T.B., van Duijnhoven, G.C., van Vliet, S.J., Krieger, E., Vriend, G., Figdor, C.G. and van Kooyk, Y. Identification of different binding sites in the dendritic cell-specific receptor DC-SIGN for intercellular adhesion molecule 3 and HIV-1. J. Biol. Chem. 277 (2002) 11314–11320. http://dx.doi.org/10.1074/jbc.M11153220010.1074/jbc.M111532200Search in Google Scholar PubMed

[34] Janković, M.M. and Milutinović, B.S. Pregnancy-associated CA125 antigen as mucin: evaluation of ferning morphology. Mol. Hum. Reprod. 13 (2007) 405–408. http://dx.doi.org/10.1093/molehr/gam02210.1093/molehr/gam022Search in Google Scholar

[35] Varki, A. Selectin ligands. Proc. Natl. Acad. Sci. USA 91 (1994) 7390–7397. http://dx.doi.org/10.1073/pnas.91.16.739010.1073/pnas.91.16.7390Search in Google Scholar

[36] Janković, M.M. and Mitić, N.M. MUC16/CA125 in the context of modular proteins with an annotated role in adhesion-related processes: in silico analysis. Int. J. Mol. Sci. 13 (2012) 10387–10400. DOI: 10.3390/ijms130810387. http://dx.doi.org/10.3390/ijms13081038710.3390/ijms130810387Search in Google Scholar

[37] Halary, F., Amara, A., Lortat-Jacob, H., Messerle, M., Delaunay, T., Houlès, C., Fieschi, F., Arenzana-Seisdedos, F., Moreau, J.F. and Déchanet-Merville, J. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17 (2002) 653–664. http://dx.doi.org/10.1016/S1074-7613(02)00447-810.1016/S1074-7613(02)00447-8Search in Google Scholar

[38] de Jong, M.A., de Witte, L., Bolmstedt, A., van Kooyk, Y. and Geijtenbeek, T.B. Dendritic cells mediate herpes simplex virus infection and transmission through the C-type lectin DC-SIGN. J. Gen. Virol. 89 (2008) 2398–2409. DOI: 10.1099/vir.0.2008/003129-0. http://dx.doi.org/10.1099/vir.0.2008/003129-010.1099/vir.0.2008/003129-0Search in Google Scholar PubMed

[39] Kämmerer, U., Rieger, L., Honig, A. and Kämpgen, E. Characterization of human dendritic cells at the materno-fetal interface. In: Immunology of Pregnancy, (Mor, G., Ed.), Springer, New York, 2006, 122–129. http://dx.doi.org/10.1007/0-387-34944-8_1210.1007/0-387-34944-8_12Search in Google Scholar

Published Online: 2014-6-22
Published in Print: 2014-6-1

© 2013 University of Wrocław, Poland

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Downloaded on 19.3.2024 from https://www.degruyter.com/document/doi/10.2478/s11658-014-0194-4/html
Scroll to top button